WHY IT MATTERS: If this research demonstrates measurable reductions in healthcare claims among medical cannabis patients, it could become the foundation for insurance coverage arguments that would lower out-of-pocket costs for patients who currently pay entirely on their own. CLINICAL OVERVIEW: Growing interest in medical cannabis as a tool for reducing overall healthcare utilization reflects a broader shift in how clinicians and insurers are beginning to think about cannabis not just as a symptom management option but as a potential cost-offset intervention. When patients gain access to effective symptom control through cannabis, they may rely less on urgent care visits, specialist consultations, and high-cost pharmaceuticals.